WLD Token

World Foundation has liquidated $65 million in WLD tokens at $0.27 each, a 76% discount to its May 2024 Series B price of $1.13, signaling severe distress at Sam Altman’s biometric identity platform. An imminent token unlock covering 52% of supply in July threatens to compound losses for investors who entered near the token’s $11.82 peak.

• World Assets completed $65 million OTC sale at $0.27 per WLD, down from $1.13 in May 2024 Series B
• Only $25 million of tokens sold carry six-month lockup; remaining $40 million immediately tradeable
• 52% of 10 billion WLD supply unlocks July 23, arriving as token trades 97% below its March 2024 peak

• 76% Discount on token price versus Series B round ten months earlier
• $0.27 Average sale price versus $11.82 all-time high in March 2024
• July 23 Date of 52% supply unlock covering five billion tokens

The World Foundation, the entity behind the iris-scanning identity platform, disclosed on March 28 that it had completed an over-the-counter placement of WLD tokens to four unnamed buyers over the preceding week, settling the first tranche on March 20. At an average price of approximately $0.27 per token, the transaction involved roughly 239 million WLD tokens changing hands.

The disclosure arrived as the token briefly touched an all-time low of $0.24 before rebounding to near the sale price, crystallizing losses for early-stage backers and highlighting accelerating deterioration in investor confidence.

World Foundation Sells Tokens at 76% Discount to Year-Old Fundraise

The price collapse is stark when measured against World’s Series B round in May 2024, when the foundation raised $135 million at $1.13 per token from prominent venture backers including Andreessen Horowitz and Bain Capital Crypto.

That round valued the project at a significantly higher market capitalization and signaled strong institutional appetite for its vision of building a decentralized identity protocol anchored to biometric data.

Less than one year later, the foundation is forced to sell tokens at a fraction of that valuation, a move typically interpreted by the market as a sign of operational strain or desperation for immediate liquidity.

The foundation framed the proceeds as directed toward core operations, research and development, orb manufacturing, and ecosystem development, standard operational categories that offer little transparency into why such a steep discount was necessary.

The sale structure itself reveals meaningful detail: of the $65 million total, only $25 million worth of tokens carry a six-month lockup period, meaning buyers could hold before selling.

The remaining $40 million was immediately available for trading, a configuration that typically suggests the seller prioritized speed and certainty of capital acquisition over orderly market absorption of the token supply.

At $0.27, WLD now trades roughly 97% below its March 2024 all-time high of $11.82.

For investors who purchased in the Series B at $1.13, the current price represents a loss of approximately 76%. This magnitude of depreciation, achieved within a single year, is consistent with structural challenges to the project’s core value proposition or material deterioration in regulatory standing and market sentiment.

Massive Token Unlock Looms as Supply Overhang Intensifies Selling Pressure

The immediate market pain may prove modest compared to what arrives in July. Data from DefiLlama indicates that a major community token unlock is scheduled for July 23, covering approximately 52% of WLD’s total supply of 10 billion tokens.

That represents 5.2 billion tokens entering circulation during a period when the token already trades near its historic floor, a configuration that typically exerts severe downward price pressure. Major supply releases of this magnitude, absent significant concurrent demand catalysts, historically precede sharp declines in token prices as new holders enter the market with selling intent.

The timing compounds institutional investor concerns. The OTC sale in March arrived at valuations already reflecting deep skepticism about the project’s near-term prospects.

An unlock covering half the supply just four months later, with no announced major partnership, product milestone, or regulatory clarification to justify demand at current prices, suggests the token may face structural headwinds through the remainder of 2026.

The concentration of supply release into a single date, rather than a gradual vesting schedule, maximizes the shock to market pricing mechanics.

Institutional investors tracking World must weigh whether the July unlock represents a predetermined vesting event tied to earlier token allocations, or whether it reflects a scheduled release that could potentially be modified or delayed by foundation governance.

The absence of detail in public disclosures about the unlock’s origin and whether it is contractually fixed or discretionary leaves material ambiguity about the project’s actual supply trajectory and the foundation’s ability to manage sell-side pressure.

Regulatory Crackdowns Across Four Continents Compound Operational Headwinds

The token collapse does not occur in a regulatory vacuum. Thailand authorities conducted a raid on an iris-scanning site linked to World’s operations in October 2025, a law enforcement action that signaled serious compliance concerns in a major Asian jurisdiction. Since then, regulatory pressure has accelerated across multiple geographies.

Indonesian authorities suspended World ID registration over unspecified compliance concerns. Brazil took the more aggressive step of outright banning the platform’s eye-scanning operations. Germany opened a formal inquiry into the project’s data handling practices.

Kenya pushed back on data privacy grounds, refusing to permit the service within its borders.

This regulatory pattern reflects a fundamental tension at the core of World’s business model: the collection and processing of biometric iris data, particularly at scale across developing markets, intersects directly with data protection regimes that are increasingly stringent and less deferential to private-sector claims of innovation or security.

Regulators across jurisdictions appear to have concluded that World’s approach to consent, data retention, and cross-border transfer of biometric information fails to meet local legal standards, regardless of the project’s stated commitment to privacy.

The cumulative effect is material. If major markets, Indonesia, Brazil, Kenya, restrict or ban the service, World’s addressable user base contracts sharply. The iris-scanning orbs that constitute the physical infrastructure for enrollment become stranded assets in those jurisdictions.

This directly undermines the economic model that justified venture funding at $1.13 per token and explains, in part, why the foundation is now forced to raise cash at $0.27.

Institutional investors must assess whether the regulatory obstacles represent temporary friction that can be resolved through compliance remediation, or whether they reflect fundamental incompatibility between the project’s data-collection model and the regulatory environment in precisely those emerging markets where the largest addressable populations live.

The World Foundation has not disclosed whether the July 23 token unlock can be deferred, modified, or canceled through governance procedures, nor has it provided forward guidance on whether additional capital raises at unfavorable valuations may be necessary to sustain operations pending regulatory resolution. Institutional investors should monitor whether World Foundation issues revised timelines for its Indonesia and Brazil operations, whether any major buyer of the $65 million token tranche is revealed and their stated thesis, and whether token price holds above the $0.24 level that briefly marked the all-time low immediately after the sale announcement.